Evidence map›Paper›PMID 39007934›Full record

ArticleZeitschrift fur Rheumatologie2024

[The German Society for Rheumatology and Clinical Immunology (DGRh) and the COVID-19 pandemic].

Anna Julia Voormann, Christof Specker

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anna Julia VoormannDeutsche Gesellschaft für Rheumatologie und Klinische Immunologie e. V., Wilhelmine-Gemberg-Weg 6, Aufgang C, 10179, Berlin, Deutschland.
Christof SpeckerDeutsche Gesellschaft für Rheumatologie und Klinische Immunologie e. V., Wilhelmine-Gemberg-Weg 6, Aufgang C, 10179, Berlin, Deutschland. specker@hhu.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic led to a global disruption of public life unprecedented in modern times due to an infectious disease, which certainly caused additional special burdens for patients with chronic diseases as well as for personnel in the healthcare system. The German Society of Rheumatology and Clinical Immunology (DGRh), with its Executive Board and two ad hoc commissions, responded promptly to the complex challenges posed by the pandemic for rheumatological care in Germany with provision of a comprehensive and professionally sound range of information and provided concrete assistance in many situations. The diverse activities of the DGRh in the context of the pandemic led to national and international attention and consideration of its committees and recommendations in national committees and guidelines.

Indexed as

Allergy and ImmunologyCOVID-19PandemicsRheumatic DiseasesRheumatologySocieties, MedicalGermanyHumansInformation supplyMedical carePublic relations workRheumatological careVaccinations

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.